| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 2.29e-22 | 114 | 39 | 14 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 7.88e-22 | 124 | 39 | 14 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 3.38e-21 | 137 | 39 | 14 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 4.37e-19 | 192 | 39 | 14 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 PCSK6 USP17L24 USP17L13 USP17L18 | 5.54e-13 | 654 | 39 | 15 | GO:0008233 |
| GeneOntologyMolecularFunction | DNA (cytosine-5-)-methyltransferase activity | DNMT3L DNMT3A | 2.22e-05 | 4 | 39 | 2 | GO:0003886 |
| GeneOntologyMolecularFunction | DNA-methyltransferase activity | DNMT3L DNMT3A | 7.76e-05 | 7 | 39 | 2 | GO:0009008 |
| GeneOntologyMolecularFunction | hyaluronic acid binding | USP17L6P USP17L24 | 1.46e-03 | 29 | 39 | 2 | GO:0005540 |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 5.66e-22 | 125 | 39 | 14 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 4.45e-21 | 144 | 39 | 14 | GO:0070646 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 HDAC7 USP17L11 USP17L15 TRIM23 USP17L24 LCMT1 USP17L13 USP17L18 | 2.31e-12 | 1074 | 39 | 17 | GO:0043687 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 HDAC7 USP17L11 USP17L15 TRIM23 USP17L24 USP17L13 USP17L18 | 1.25e-11 | 1009 | 39 | 16 | GO:0070647 |
| GeneOntologyBiologicalProcess | protein deubiquitination involved in ubiquitin-dependent protein catabolic process | USP17L6P USP17L24 | 9.68e-05 | 8 | 39 | 2 | GO:0071947 |
| GeneOntologyBiologicalProcess | autosome genomic imprinting | DNMT3L DNMT3A | 1.24e-04 | 9 | 39 | 2 | GO:0141068 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L6P USP17L5 USP17L21 USP17L10 DHRS4 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 2.66e-08 | 1293 | 38 | 14 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L6P USP17L5 USP17L21 USP17L10 DHRS4 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 2.82e-08 | 1299 | 38 | 14 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L6P USP17L5 USP17L21 USP17L10 DHRS4 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 3.68e-08 | 1327 | 38 | 14 | GO:0042175 |
| GeneOntologyCellularComponent | heterochromatin | KDM4E DNMT3L DNMT3A | 8.17e-04 | 101 | 38 | 3 | GO:0000792 |
| MousePheno | increased trophectoderm apoptosis | USP17L15 USP17L13 | 5.99e-05 | 8 | 21 | 2 | MP:0012119 |
| MousePheno | decreased regulatory T cell number | CD27 USP17L15 USP17L13 | 1.15e-04 | 64 | 21 | 3 | MP:0004974 |
| MousePheno | abnormal DNA methylation during gametogenesis | DNMT3L DNMT3A | 1.17e-04 | 11 | 21 | 2 | MP:0008878 |
| MousePheno | abnormal imprinting | DNMT3L DNMT3A | 2.88e-04 | 17 | 21 | 2 | MP:0003787 |
| Domain | HABP4_PAI-RBP1 | USP17L5 USP17L21 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 1.08e-27 | 16 | 36 | 11 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L5 USP17L21 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 1.08e-27 | 16 | 36 | 11 | IPR006861 |
| Domain | USP_CS | USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 1.54e-21 | 66 | 36 | 12 | IPR018200 |
| Domain | USP_1 | USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 3.32e-21 | 70 | 36 | 12 | PS00972 |
| Domain | UCH | USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 3.99e-21 | 71 | 36 | 12 | PF00443 |
| Domain | USP_2 | USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 3.99e-21 | 71 | 36 | 12 | PS00973 |
| Domain | USP_3 | USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 4.78e-21 | 72 | 36 | 12 | PS50235 |
| Domain | USP_dom | USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 4.78e-21 | 72 | 36 | 12 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L24 USP17L13 USP17L18 | 4.78e-21 | 72 | 36 | 12 | IPR001394 |
| Domain | ADD | DNMT3L DNMT3A | 2.16e-05 | 4 | 36 | 2 | IPR025766 |
| Domain | ADD | DNMT3L DNMT3A | 2.16e-05 | 4 | 36 | 2 | PS51533 |
| Domain | - | HHIPL1 TENM4 | 2.56e-03 | 39 | 36 | 2 | 2.120.10.30 |
| Domain | Znf_FYVE_PHD | TCF20 DNMT3L DNMT3A | 2.82e-03 | 147 | 36 | 3 | IPR011011 |
| Domain | 6-blade_b-propeller_TolB-like | HHIPL1 TENM4 | 3.54e-03 | 46 | 36 | 2 | IPR011042 |
| Pathway | REACTOME_RAS_PROCESSING | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 6.08e-26 | 45 | 30 | 13 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 3.36e-17 | 191 | 30 | 13 | MM15289 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 2.30e-16 | 221 | 30 | 13 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 2.12e-15 | 262 | 30 | 13 | MM15286 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.18e-14 | 299 | 30 | 13 | M27574 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 2.60e-14 | 318 | 30 | 13 | MM15278 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 HDAC7 USP17L11 USP17L15 USP17L24 USP17L13 DNMT3A USP17L18 | 6.22e-08 | 1475 | 30 | 15 | M19806 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 HDAC7 USP17L11 USP17L15 USP17L13 USP17L18 | 2.43e-07 | 1389 | 30 | 14 | MM15307 |
| Pathway | KEGG_CYSTEINE_AND_METHIONINE_METABOLISM | DNMT3L DNMT3A | 2.35e-03 | 34 | 30 | 2 | M10911 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 9.42e-35 | 21 | 39 | 13 | 12447969 |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 9.42e-35 | 21 | 39 | 13 | 11468161 |
| Pubmed | DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 9.42e-35 | 21 | 39 | 13 | 18980247 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 9.42e-35 | 21 | 39 | 13 | 8756639 |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 9.42e-35 | 21 | 39 | 13 | 8622927 |
| Pubmed | DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 9.42e-35 | 21 | 39 | 13 | 14583620 |
| Pubmed | JAK2 is required for induction of the murine DUB-1 gene. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 2.30e-34 | 22 | 39 | 13 | 9154835 |
| Pubmed | Cdc25A and Dub3 in a high-stakes balancing act. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 2.81e-34 | 33 | 39 | 14 | 20228807 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 4.78e-34 | 34 | 39 | 14 | 19188362 |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 4.78e-34 | 34 | 39 | 14 | 20715989 |
| Pubmed | Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 4.78e-34 | 34 | 39 | 14 | 17109758 |
| Pubmed | Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 4.78e-34 | 34 | 39 | 14 | 11941478 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 4.78e-34 | 34 | 39 | 14 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 4.78e-34 | 34 | 39 | 14 | 20368735 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 4.78e-34 | 34 | 39 | 14 | 15780755 |
| Pubmed | The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 4.78e-34 | 34 | 39 | 14 | 20388806 |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 4.78e-34 | 34 | 39 | 14 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 4.78e-34 | 34 | 39 | 14 | 20403174 |
| Pubmed | The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 4.78e-34 | 34 | 39 | 14 | 10936051 |
| Pubmed | The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 4.78e-34 | 34 | 39 | 14 | 21448158 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 7.96e-34 | 35 | 39 | 14 | 21239494 |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 7.96e-34 | 35 | 39 | 14 | 16611142 |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 1.15e-33 | 24 | 39 | 13 | 8995226 |
| Pubmed | The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 1.30e-33 | 36 | 39 | 14 | 20147298 |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 2.09e-33 | 37 | 39 | 14 | 20228808 |
| Pubmed | Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 2.40e-33 | 25 | 39 | 13 | 21115691 |
| Pubmed | Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 4.80e-33 | 26 | 39 | 13 | 35816173 |
| Pubmed | Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 3.12e-32 | 29 | 39 | 13 | 32527007 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 1.61e-28 | 50 | 39 | 13 | 31806660 |
| Pubmed | USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities. | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 TENM4 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 8.90e-15 | 674 | 39 | 14 | 37196079 |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L19 USP17L12 USP17L17 USP17L20 USP17L11 USP17L18 | 6.45e-11 | 119 | 39 | 7 | 28625976 |
| Pubmed | The inherent processivity of the human de novo methyltransferase 3A (DNMT3A) is enhanced by DNMT3L. | DNMT3L DNMT3A | 1.23e-06 | 2 | 39 | 2 | 20630873 |
| Pubmed | Combined and differential roles of ADD domains of DNMT3A and DNMT3L on DNA methylation landscapes in mouse germ cells. | DNMT3L DNMT3A | 1.23e-06 | 2 | 39 | 2 | 38627502 |
| Pubmed | The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a. | DNMT3L DNMT3A | 1.23e-06 | 2 | 39 | 2 | 12481029 |
| Pubmed | HBx induces hypomethylation of distal intragenic CpG islands required for active expression of developmental regulators. | DNMT3L DNMT3A | 1.23e-06 | 2 | 39 | 2 | 24941955 |
| Pubmed | Both combinatorial K4me0-K36me3 marks on sister histone H3s of a nucleosome are required for Dnmt3a-Dnmt3L mediated de novo DNA methylation. | DNMT3L DNMT3A | 1.23e-06 | 2 | 39 | 2 | 32173286 |
| Pubmed | CG dinucleotide periodicities recognized by the Dnmt3a-Dnmt3L complex are distinctive at retroelements and imprinted domains. | DNMT3L DNMT3A | 1.23e-06 | 2 | 39 | 2 | 19921333 |
| Pubmed | Dynamic CpG island methylation landscape in oocytes and preimplantation embryos. | DNMT3L DNMT3A | 1.23e-06 | 2 | 39 | 2 | 21706000 |
| Pubmed | Physical and functional interactions between the human DNMT3L protein and members of the de novo methyltransferase family. | DNMT3L DNMT3A | 1.23e-06 | 2 | 39 | 2 | 15861382 |
| Pubmed | Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. | DNMT3L DNMT3A | 1.23e-06 | 2 | 39 | 2 | 17713477 |
| Pubmed | Dnmt3a2 targets endogenous Dnmt3L to ES cell chromatin and induces regional DNA methylation. | DNMT3L DNMT3A | 1.23e-06 | 2 | 39 | 2 | 16999741 |
| Pubmed | Forced expression of DNA methyltransferases during oocyte growth accelerates the establishment of methylation imprints but not functional genomic imprinting. | DNMT3L DNMT3A | 1.23e-06 | 2 | 39 | 2 | 24599402 |
| Pubmed | Formation of nucleoprotein filaments by mammalian DNA methyltransferase Dnmt3a in complex with regulator Dnmt3L. | DNMT3L DNMT3A | 1.23e-06 | 2 | 39 | 2 | 18945701 |
| Pubmed | Mechanism of stimulation of catalytic activity of Dnmt3A and Dnmt3B DNA-(cytosine-C5)-methyltransferases by Dnmt3L. | DNMT3L DNMT3A | 3.67e-06 | 3 | 39 | 2 | 15671018 |
| Pubmed | DNMT3L facilitates DNA methylation partly by maintaining DNMT3A stability in mouse embryonic stem cells. | DNMT3L DNMT3A | 3.67e-06 | 3 | 39 | 2 | 30321403 |
| Pubmed | Gene-specific timing and epigenetic memory in oocyte imprinting. | DNMT3L DNMT3A | 3.67e-06 | 3 | 39 | 2 | 14998934 |
| Pubmed | Co-expression of de novo DNA methyltransferases Dnmt3a2 and Dnmt3L in gonocytes of mouse embryos. | DNMT3L DNMT3A | 3.67e-06 | 3 | 39 | 2 | 15567719 |
| Pubmed | Genetic evidence for a maternal effect locus controlling genomic imprinting and growth. | DNMT3L DNMT3A | 3.67e-06 | 3 | 39 | 2 | 16283622 |
| Pubmed | DNA methyltransferase expression in the mouse germ line during periods of de novo methylation. | DNMT3L DNMT3A | 3.67e-06 | 3 | 39 | 2 | 15739230 |
| Pubmed | Coordinate regulation of DNA methyltransferase expression during oogenesis. | DNMT3L DNMT3A | 3.67e-06 | 3 | 39 | 2 | 17445268 |
| Pubmed | DNMT3L stimulates the DNA methylation activity of Dnmt3a and Dnmt3b through a direct interaction. | DNMT3L DNMT3A | 3.67e-06 | 3 | 39 | 2 | 15105426 |
| Pubmed | In vivo control of CpG and non-CpG DNA methylation by DNA methyltransferases. | DNMT3L DNMT3A | 3.67e-06 | 3 | 39 | 2 | 22761581 |
| Pubmed | Structural insight into autoinhibition and histone H3-induced activation of DNMT3A. | DNMT3L DNMT3A | 3.67e-06 | 3 | 39 | 2 | 25383530 |
| Pubmed | Interactions within the mammalian DNA methyltransferase family. | DNMT3L DNMT3A | 3.67e-06 | 3 | 39 | 2 | 12777184 |
| Pubmed | Role of the Dnmt3 family in de novo methylation of imprinted and repetitive sequences during male germ cell development in the mouse. | DNMT3L DNMT3A | 3.67e-06 | 3 | 39 | 2 | 17616512 |
| Pubmed | DNMT3L modulates significant and distinct flanking sequence preference for DNA methylation by DNMT3A and DNMT3B in vivo. | DNMT3L DNMT3A | 3.67e-06 | 3 | 39 | 2 | 20838592 |
| Pubmed | Regulation of DNA methylation activity through Dnmt3L promoter methylation by Dnmt3 enzymes in embryonic development. | DNMT3L DNMT3A | 3.67e-06 | 3 | 39 | 2 | 18544626 |
| Pubmed | Human intelligence and polymorphisms in the DNA methyltransferase genes involved in epigenetic marking. | DNMT3L DNMT3A | 7.34e-06 | 4 | 39 | 2 | 20593030 |
| Pubmed | DNA methylation of retrotransposon genes is regulated by Piwi family members MILI and MIWI2 in murine fetal testes. | DNMT3L DNMT3A | 7.34e-06 | 4 | 39 | 2 | 18381894 |
| Pubmed | De novo DNA methylation drives 5hmC accumulation in mouse zygotes. | DNMT3L DNMT3A | 7.34e-06 | 4 | 39 | 2 | 26751286 |
| Pubmed | De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. | DNMT3L DNMT3A | 7.34e-06 | 4 | 39 | 2 | 18953337 |
| Pubmed | The loss of global DNA methylation due to decreased DNMT expression in the postnatal mouse ovaries may associate with infertility emerging during ovarian aging. | DNMT3L DNMT3A | 7.34e-06 | 4 | 39 | 2 | 32514790 |
| Pubmed | De novo DNA methylation through the 5'-segment of the H19 ICR maintains its imprint during early embryogenesis. | DNMT3L DNMT3A | 7.34e-06 | 4 | 39 | 2 | 26417043 |
| Pubmed | Embryonic demise caused by targeted disruption of a cysteine protease Dub-2. | USP17L15 USP17L13 | 7.34e-06 | 4 | 39 | 2 | 22984479 |
| Pubmed | Mouse oocyte methylomes at base resolution reveal genome-wide accumulation of non-CpG methylation and role of DNA methyltransferases. | DNMT3L DNMT3A | 7.34e-06 | 4 | 39 | 2 | 23637617 |
| Pubmed | Superovulation induces defective methylation in line-1 retrotransposon elements in blastocyst. | DNMT3L DNMT3A | 7.34e-06 | 4 | 39 | 2 | 23866265 |
| Pubmed | Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs. | DNMT3L DNMT3A | 1.22e-05 | 5 | 39 | 2 | 24074865 |
| Pubmed | A systematic search for DNA methyltransferase polymorphisms reveals a rare DNMT3L variant associated with subtelomeric hypomethylation. | DNMT3L DNMT3A | 1.22e-05 | 5 | 39 | 2 | 19246518 |
| Pubmed | Windows for sex-specific methylation marked by DNA methyltransferase expression profiles in mouse germ cells. | DNMT3L DNMT3A | 1.22e-05 | 5 | 39 | 2 | 15063176 |
| Pubmed | Ectopic expression of DNA methyltransferases DNMT3A2 and DNMT3L leads to aberrant hypermethylation and postnatal lethality in mice. | DNMT3L DNMT3A | 2.56e-05 | 7 | 39 | 2 | 30834655 |
| Pubmed | Catalytically inactive Dnmt3b rescues mouse embryonic development by accessory and repressive functions. | DNMT3L DNMT3A | 2.56e-05 | 7 | 39 | 2 | 31558711 |
| Pubmed | Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. | DNMT3L DNMT3A | 2.56e-05 | 7 | 39 | 2 | 11934864 |
| Pubmed | DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. | DNMT3L DNMT3A | 2.56e-05 | 7 | 39 | 2 | 17687327 |
| Pubmed | Telomere lengthening early in development. | DNMT3L DNMT3A | 2.56e-05 | 7 | 39 | 2 | 17982445 |
| Pubmed | KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. | DNMT3L DNMT3A | 3.42e-05 | 8 | 39 | 2 | 19727073 |
| Pubmed | Synergistic function of DNA methyltransferases Dnmt3a and Dnmt3b in the methylation of Oct4 and Nanog. | DNMT3L DNMT3A | 3.42e-05 | 8 | 39 | 2 | 17938196 |
| Pubmed | SPOCD1 is an essential executor of piRNA-directed de novo DNA methylation. | DNMT3L DNMT3A | 3.42e-05 | 8 | 39 | 2 | 32674113 |
| Pubmed | Plasticity in Dnmt3L-dependent and -independent modes of de novo methylation in the developing mouse embryo. | DNMT3L DNMT3A | 3.42e-05 | 8 | 39 | 2 | 23293288 |
| Pubmed | ZFP281 controls transcriptional and epigenetic changes promoting mouse pluripotent state transitions via DNMT3 and TET1. | DNMT3L DNMT3A | 4.39e-05 | 9 | 39 | 2 | 38237590 |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | USP17L6P USP17L15 | 5.48e-05 | 10 | 39 | 2 | 24207026 |
| Pubmed | The testis-specific factor CTCFL cooperates with the protein methyltransferase PRMT7 in H19 imprinting control region methylation. | DNMT3L DNMT3A | 5.48e-05 | 10 | 39 | 2 | 17048991 |
| Pubmed | DNMT3A-dependent DNA methylation is required for spermatogonial stem cells to commit to spermatogenesis. | DNMT3L DNMT3A | 6.70e-05 | 11 | 39 | 2 | 35410378 |
| Pubmed | Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells. | USP17L6P USP17L15 | 8.03e-05 | 12 | 39 | 2 | 24695638 |
| Pubmed | Cytoplasmic compartmentalization of the fetal piRNA pathway in mice. | DNMT3L DNMT3A | 8.03e-05 | 12 | 39 | 2 | 20011505 |
| Pubmed | SWI/SNF chromatin remodeling complex is required for initiation of sex-dependent differentiation in mouse germline. | DNMT3L DNMT3A | 9.48e-05 | 13 | 39 | 2 | 34912016 |
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | USP17L6P USP17L15 | 1.11e-04 | 14 | 39 | 2 | 11793228 |
| Pubmed | Multiplex rt-PCR expression analysis of developmentally important genes in individual mouse preimplantation embryos and blastomeres. | DNMT3L DNMT3A | 1.46e-04 | 16 | 39 | 2 | 18784354 |
| Pubmed | An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. | ZBTB10 DNMT3L DNMT3A | 1.48e-04 | 91 | 39 | 3 | 20362542 |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | USP17L6P USP17L15 | 2.07e-04 | 19 | 39 | 2 | 28067227 |
| Pubmed | The TDRD9-MIWI2 complex is essential for piRNA-mediated retrotransposon silencing in the mouse male germline. | DNMT3L DNMT3A | 2.30e-04 | 20 | 39 | 2 | 20059948 |
| Pubmed | Rex1/Zfp42 as an epigenetic regulator for genomic imprinting. | DNMT3L DNMT3A | 4.23e-04 | 27 | 39 | 2 | 21233130 |
| Interaction | FLT3 interactions | USP17L21 USP17L19 USP17L12 USP17L17 USP17L20 USP17L11 USP17L18 | 8.51e-07 | 318 | 34 | 7 | int:FLT3 |
| Interaction | ZNF250 interactions | GUCD1 ZCCHC7 YJU2B TRIM23 | 5.84e-05 | 126 | 34 | 4 | int:ZNF250 |
| Cytoband | 4p16.1 | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 8.59e-30 | 79 | 39 | 14 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 3.42e-23 | 222 | 39 | 14 | chr4p16 |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 6.60e-24 | 86 | 37 | 13 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 2.52e-22 | 112 | 37 | 13 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 3.12e-20 | 160 | 37 | 13 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 CD27 USP17L20 USP17L11 USP17L15 USP17L13 USP17L18 | 9.82e-14 | 647 | 37 | 14 | MM981 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 COA7 USP17L11 USP17L15 USP17L13 USP17L18 | 8.53e-11 | 1072 | 37 | 14 | MM1031 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 LCMT1 USP17L13 USP17L18 | 3.67e-10 | 1198 | 37 | 14 | MM1062 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 LCMT1 USP17L13 USP17L18 | 4.95e-10 | 1226 | 37 | 14 | MM979 |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_DN | TCF20 ALS2CL CD27 DNMT3A | 1.07e-04 | 175 | 37 | 4 | M6328 |
| Coexpression | GSE3565_DUSP1_VS_WT_SPLENOCYTES_DN | TCF20 CD27 HDAC7 DNMT3A | 1.16e-04 | 179 | 37 | 4 | M6324 |
| Coexpression | GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP | GUCD1 ALS2CL YJU2B DNMT3A | 1.75e-04 | 199 | 37 | 4 | M9269 |
| Drug | vinclozolin | TCF20 DNMT3L DNMT3A | 2.48e-05 | 48 | 27 | 3 | CID000039676 |
| Drug | 5-bromocytosine | DNMT3L DNMT3A | 6.06e-05 | 10 | 27 | 2 | CID000075233 |
| Drug | Tropine [120-29-6]; Down 200; 28.4uM; HL60; HT_HG-U133A | ALS2CL SGCB TRIM23 PCSK6 | 8.00e-05 | 196 | 27 | 4 | 6147_DN |
| Drug | Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; MCF7; HT_HG-U133A | ALS2CL PCSK6 ANGEL2 DNMT3A | 8.16e-05 | 197 | 27 | 4 | 7360_UP |
| Drug | Propafenone hydrochloride [34183-22-7]; Down 200; 10.6uM; MCF7; HT_HG-U133A | SGCB TRIM23 ANGEL2 DNMT3A | 8.16e-05 | 197 | 27 | 4 | 2871_DN |
| Drug | Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A | SGCB HDAC7 PCSK6 DNMT3A | 8.32e-05 | 198 | 27 | 4 | 3477_UP |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; MCF7; HT_HG-U133A | ALS2CL HDAC7 PCSK6 ANGEL2 | 8.49e-05 | 199 | 27 | 4 | 6810_DN |
| Drug | troglitazone; Up 200; 10uM; HL60; HT_HG-U133A | SGCB HDAC7 TRIM23 DNMT3A | 8.49e-05 | 199 | 27 | 4 | 6191_UP |
| Drug | Naproxen [22204-53-1]; Up 200; 17.4uM; HL60; HT_HG-U133A | ALS2CL HDAC7 COA7 PCSK6 | 8.65e-05 | 200 | 27 | 4 | 1869_UP |
| Drug | C-E6 | DNMT3L DNMT3A | 8.87e-05 | 12 | 27 | 2 | CID000444208 |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 3.30e-31 | 46 | 37 | 14 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L6P USP17L5 USP17L21 USP17L10 USP17L19 USP17L12 USP17L22 USP17L17 USP17L20 USP17L11 USP17L15 USP17L24 USP17L13 USP17L18 | 2.09e-28 | 69 | 37 | 14 | DOID:1682 (implicated_via_orthology) |
| Disease | mean arterial pressure | ZBTB10 ZCCHC7 TCF20 SLCO6A1 HDAC7 | 3.78e-04 | 499 | 37 | 5 | EFO_0006340 |
| Disease | isthmus cingulate cortex volume measurement | TENM4 TCF20 | 4.88e-04 | 26 | 37 | 2 | EFO_0010310 |
| Disease | Mental deterioration | TENM4 SLCO6A1 | 6.08e-04 | 29 | 37 | 2 | HP_0001268 |
| Disease | bipolar disorder | TENM4 ZCCHC7 TCF20 HDAC7 | 5.73e-03 | 577 | 37 | 4 | MONDO_0004985 |